´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ Update on MM(Multiple Myeloma) 2022 : 2022-02-12±³À°ÀÏÀÚ : 2022-02-12
±³À°Àå¼Ò : THE K Hotel 2F ,°¡¾ß±Ý Hall
±³À°ÁÖÁ¦ :
Update on MM(Multiple Myeloma) 2022ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸
´ã´çÀÚ : ¼È¿Áø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
kmmwp_office@naver.com ±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í COVID-19 ¹æ¿ªÁöħ¿¡ µû¶ó Âü¿© Àοø º¯µ¿ °¡´ÉÇϸç, »çÀü µî·ÏÀº Á¶±â ¸¶°¨ µÉ ¼ö ÀÖ½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 10:30~11:00 Genomics and epigenomics of MM ¿ï»êÀÇ´ë(±è¹Ì¿µ)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 11:00~11:30 MGUS and smoldering MM °í·ÁÀÇ´ë(°°¡¿ø)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 11:40~12:10 Imaging approaches for MM °æºÏÀÇ´ë(Á¶ÈñÁ¤)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 12:10~12:40 MRD assessment ¼¿ïÀÇ´ë(Ȳ»ó¹Ì)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 13:40~14:10 Treatment of Newly Diagnosed Myeloma Transplant Eligible µ¿¾ÆÀÇ´ë(ÀÌÁöÇö)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 14:10~14:40 Treatment of Newly Diagnosed Myeloma Non-Transplant ±¹¸³¾Ï¼¾ÅÍ(Á¤Á¾Çå)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 14:40~15:10 Consolidation and Maintenance Strategies for MM Àü³²ÀÇ´ë(¼Û°¡¿µ)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 15:20~15:50 Treatment Options for Relapsed/Refractory patients °¡Å縯ÀÇ´ë(¹Ú¼º¼ö)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 15:50~16:20 Immunologic treatment options for RRMM °¡ÃµÀÇ´ë(À¯ÄèÇÑ)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 16:25~16:55 Cellular Immunotherapies for MM ¼º±Õ°üÀÇ´ë(À±»óÀº)
±³À°½Ã°£ 02-12 THE K Hotel 2F ,°¡¾ß±Ý Hall 16:55~17:25 Rare diseases including Amyloidosis, POEMS and WM ¿¬¼¼ÀÇ´ë(Çö½Å¿µ)